STAA / 3 Reasons Why Growth Investors Shouldn't Overlook Staar Surgical (STAA)

STAAR Surgical Company (NASDAQ:STAA ) Q3 2023 Earnings Conference Call November 1, 2023 4:30 PM ET Company Participants Brian Moore - Vice President-I more_horizontal

STAAR Surgical Company's Q2 FY'23 earnings missed consensus estimates. The key revenue driver for STAA is its Implantable Collamer Lenses, which saw a more_horizontal

Staar Surgical (STAA) came out with quarterly earnings of $0.40 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to e more_horizontal

STAAR Surgical is on the cusp of an acceleration in earnings and growth courtesy of its entrance into the US market. It is profitable, generates posit more_horizontal

STAAR Surgical Company (NASDAQ:STAA ) Q1 2023 Earnings Conference Call May 3, 2023 4:30 PM ET Company Participants Brian Moore - VP of Investor, Media more_horizontal

STAAR Surgical Company (NASDAQ:STAA ) Q4 2022 Earnings Conference Call February 21, 2023 4:30 PM ET Company Participants Brian Moore - Vice President more_horizontal

Staar Surgical (STAA) delivered earnings and revenue surprises of -6.67% and 0.50%, respectively, for the quarter ended December 2022. Do the numbers more_horizontal

Strong growth in EVO ICL units led by increased market adoption is likely to have driven STAAR Surgical's (STAA) Q4 revenues. more_horizontal